Fig. 1

Clinical studies investigating the predictive value of HRD in ovarian cancer measured by commercial genomic sequencing. Abbreviations: PFS = progressed free survival; NE = not end; HR = harzd ratio; gBRCA1/2 m = germline BRCA1/2 mutation; LOH = loss of heterozygosity; ORR = overall response rate; ITT = intention to treat; gBRCAwt = germline BRCA wildtype; HRD = homologous recombination deficient